✦ LIBER ✦

Successful re-treatment with gefitinib for carcinomatous meningitis as disease recurrence of non-small-cell lung cancer

✍ Scribed by Hashimoto, Naozumi; Imaizumi, Kazuyoshi; Honda, Toyohiro; Kawabe, Tsutomu; Nagasaka, Tetsuro; Shimokata, Kaoru; Hasegawa, Yoshinori

Book ID: 119319424
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 467 KB
Volume: 53
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2006.05.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful treatment with erlotinib of s

Successful treatment with erlotinib of severe neutropenia induced by gefitinib in a patient with advanced non-small cell lung cancer

✍ Araya, Tomoyuki; Kasahara, Kazuo; Demura, Yoshiki; Matsuoka, Hiroki; Nishitsuji, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 315 KB

P-617 Gefitinib (ZD 1839, Iressa) as a l

P-617 Gefitinib (ZD 1839, Iressa) as a last option for patients with recurrent non-small cell lung cancer (NSCLC)

✍ Haringhuizen, Annebeth; Vaessen, Heleen F.R.; Baas, Paul; van Zandwijk, Nico 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Re-irradiation for Locally-Recurrent Non

Re-irradiation for Locally-Recurrent Non-Small Cell Lung Cancer With Stereotactic Body Radiation Therapy as Initial or Salvage Treatment

✍ Schutzer, M.E.; Weiss, E. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Efficacy of gefitinib as a first-line si

Efficacy of gefitinib as a first-line single agent treatment in patients with advanced non-small cell lung cancer

✍ Yin, Yongmei; Geng, Yiting; Li, Xiaodong; Hu, Xiaoli; Chen, Xiaofeng; Li, Wei; S 📂 Article 📅 2009 🏛 Chinese Electronic Periodical Services 🌐 English ⚖ 490 KB

Predictive Factors for Interstitial Lung

Predictive Factors for Interstitial Lung Disease, Antitumor Response, and Survival in Non-Small-Cell Lung Cancer Patients Treated With Gefitinib

✍ Ando, M. 📂 Article 📅 2006 🏛 American Society of Clinical Oncology 🌐 English ⚖ 294 KB

P-613 The Israeli experience with gefiti

P-613 The Israeli experience with gefitinib (‘Iressa’, ZD1839) as single agent treatment of advanced non-small-cell lung cancer

✍ Gips, M.; Heching, Y.; Levitt, M.; Kuten, A.; Shmueli, E.; Segal, A.; Peretz, T. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 194 KB